NOXOPHARM LIMITED
Who is NOXOPHARM LIMITED?
Noxopharm Limited (ASX:NOX) is a clinical-stage Australian biotech company discovering and developing novel treatments for cancer and inflammation, including a pioneering technology to improve the safety profile of a wide range of mRNA medicines. The company utilises specialist in-house capabilitie...See more
Industry & Specialities
Others
Countries of Operation
Australia New Zealand
Headquarters:
Australia
Company Type:
MNC / Large Enterprise
Company size:
11-50 Employees
Year Founded:
2015 (11 years)
Address:
SUITE 71, 159 RIDGECROP DRIVE; SYDNEY - CASTLE HILL, NEW SOUTH WALES 2154, AU
Employees by Department
- IT / Product (1)
- Sales (1)
- The Rest (7)
- Total (9)
Key Decision Makers
Graham Kelly
Group CEO
Brett Samuel
IT Manager
Xiang Li
Senior Research Scientist
Boris Patkin
NED Noxopharm Ltd joined 25 March 2020
Insight
Signals
At a glance- Operates in multiple countries
* This information is provided to the best of our research ability and we make no warranties for any inaccuracies or omissions.
Employees by Seniority
C-level
3employees
Senior
1employees
Non-managers
1employees
Financials
LOW
spending power
Funding Status
Publicly listed on stock exchange
Associated Legal Entities
0 entities
Discover More Companies
Lookalike companies
Featured Lists
- SMEs in Singapore
- MNCs / Large Enterprises in Singapore
Frequently Asked Questions (FAQ)
- How long has NOXOPHARM LIMITED been operating for?
- What is the funding status of NOXOPHARM LIMITED?
- Where is NOXOPHARM LIMITED's headquarter?
- What NOXOPHARM LIMITED's spending power?
- Does NOXOPHARM LIMITED have a presence in the domain it operates in?